Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 6, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,882	6,125	4,871	8,293	7,864	6,524
Market Cap Growth	-48.58%	25.74%	-41.27%	5.46%	20.54%	195.52%
Enterprise Value	2,832	6,262	5,027	8,273	8,078	6,675
Last Close Price	226.19	478.56	381.92	654.54	636.01	-
PE Ratio	37.12	86.16	44.56	55.87	52.79	53.78
PS Ratio	1.67	3.66	2.72	5.89	6.81	5.79
PB Ratio	1.05	2.88	2.35	4.29	5.37	4.91
P/TBV Ratio	1.05	2.90	2.38	4.34	5.38	4.92
P/OCF Ratio	-	-	-	-	191.38	51.08
EV/Sales Ratio	1.65	3.74	2.80	5.87	7.00	5.92
EV/EBITDA Ratio	15.03	33.48	22.67	34.63	34.27	34.62
EV/EBIT Ratio	23.73	53.10	32.95	46.92	45.14	39.67
Debt / Equity Ratio	0.14	0.16	0.15	0.13	0.18	0.14
Debt / EBITDA Ratio	2.05	1.81	1.40	1.08	1.09	0.98
Net Debt / Equity Ratio	-0.02	0.14	0.08	0.03	0.15	0.11
Net Debt / EBITDA Ratio	-0.27	1.61	0.74	0.21	0.93	0.77
Net Debt / FCF Ratio	-	-2.90	-1.25	-0.38	-4.88	-2.87
Asset Turnover	-	0.57	0.63	0.56	0.55	0.60
Inventory Turnover	-	1.42	1.80	2.04	3.37	6.42
Quick Ratio	-	1.25	1.09	1.31	1.19	1.48
Current Ratio	-	2.11	1.89	1.98	1.69	1.80
Return on Equity (ROE)	-	3.12%	4.74%	8.67%	10.67%	9.55%
Return on Assets (ROA)	-	2.49%	3.33%	4.37%	5.33%	5.61%
Return on Invested Capital (ROIC)	3.38%	3.36%	5.25%	8.31%	9.32%	8.97%
Return on Capital Employed (ROCE)	-	5.40%	7.30%	9.00%	11.70%	12.00%
Earnings Yield	2.69%	1.16%	2.24%	1.79%	1.89%	1.86%
FCF Yield	-	-1.69%	-2.67%	-1.55%	-0.57%	-0.80%
Dividend Yield	0.45%	0.21%	0.26%	0.15%	0.16%	-
Payout Ratio	-	17.89%	11.57%	8.52%	8.20%	5.04%
Buyback Yield / Dilution	-9.75%	-0.44%	-0.07%	-3.56%	-	-0.56%
Total Shareholder Return	-9.30%	-0.23%	0.20%	-3.40%	0.16%	-0.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.